Skip to content

Clinical Efficacy and Mechanism of Alpinia Oxyphylla - Clinacanthus nutans in Treating DKD by Regulating ChemR23 Signal Pathway

Clinical Efficacy and Mechanism of Alpinia Oxyphylla - Clinacanthus nutans in Treating DKD by Regulating ChemR23 Signal Pathway

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122764
Enrollment
Unknown
Registered
2026-04-17
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic kidney disease

Interventions

Observation Group:Basic treatment (health education, low-salt, low-fat, low-protein diabetic diet) + Yizhi Ren - Crotalaria (Yizhi Ren 10g, Crotalaria 10g, 20g/day, decoction twice daily for 8 weeks)
Control Group:Basic treatment (health education, low-salt, low-fat, low-protein diabetic diet) + Canagliflozin tablets (100mg, once daily, oral administration before breakfast for 8 weeks)
Normal Group:None (healthy individuals undergoing routine physical examination, only baseline and post-8-week treatment inflammatory markers detected)

Sponsors

Hainan Medical College First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with DKD who visited the outpatient department of Traditional Chinese Medicine or were hospitalized in our hospital voluntarily enrolled and cooperated with this study, and signed the informed consent form

Exclusion criteria

Exclusion criteria: 1. Under 18 years old or over 80 years old; 2. Combined with severe dysfunction of the heart, liver and lungs; 3. Pregnant or lactating women; 4. Combined with severe coagulation dysfunction; 5. People with allergic constitutions; 6. eGFR < 45 mL/min/1.73 m^2; 7. Accompanied by severe mental and psychological disorders; 8. Has been enrolled in other clinical studies; 9. Allergic to capagliflozin, Indocarpus or crocodile's mouth flower; 10. Use insulin.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose and kidney function;

Secondary

MeasureTime frame
IL-6?IL-1ß?IL-18?TNF-a?TGF-ß1 and NLRP3;Liver function and blood routine;

Countries

China

Contacts

Public ContactXie Dandan

Hainan Medical College First Affiliated Hospital

254862958@qq.com+86 898 66772321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026